Drosophila Antimicrobial Peptides and Lysozymes Regulate Gut Microbiota Composition and Abundance

Total Page:16

File Type:pdf, Size:1020Kb

Drosophila Antimicrobial Peptides and Lysozymes Regulate Gut Microbiota Composition and Abundance bioRxiv preprint doi: https://doi.org/10.1101/2021.03.19.436153; this version posted March 19, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Drosophila antimicrobial peptides and lysozymes regulate gut 2 microbiota composition and abundance 3 4 A. Marraa, M.A. Hansona, S. Kondob, B. Erkosara #, and B. Lemaitrea # 5 6 a Global Health Institute, School of Life Science, École Polytechnique Fédérale de Lausanne 7 (EPFL), Lausanne, Switzerland. 8 b Invertebrate Genetics Laboratory, Genetic Strains Research Center, National Institute of 9 Genetics, Mishima, Japan 10 11 Running title: Microbiota and Immune effectors 12 13 # Joint last authors. Correspondence to B. Lemaitre ([email protected]), B. Erkosar 14 ([email protected]) 15 16 ORCID IDs: 17 18 Marra: https://orcid.org/0000-0002-3181-634X 19 Hanson: https://orcid.org/0000-0002-6125-3672 20 Erkosar: https://orcid.org/0000-0003-1152-6772 21 Lemaitre: https://orcid.org/0000-0001-7970-1667 22 23 Keywords: Microbiota, innate immunity, aging, gnotobiotic animals, immune effectors, gut 24 25 bioRxiv preprint doi: https://doi.org/10.1101/2021.03.19.436153; this version posted March 19, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 26 Abstract 27 28 The gut microbiota affects the physiology and metabolism of animals and its alteration can lead 29 to diseases such as gut dysplasia or metabolic disorders. Several reports have shown that the 30 immune system plays an important role in shaping both bacterial community composition and 31 abundance in Drosophila, and that immune deficit, especially during aging, negatively affects 32 microbiota richness and diversity. However, there has been little study at the effector level to 33 demonstrate how immune pathways regulate the microbiota. A key set of Drosophila immune 34 effectors are the antimicrobial peptides (AMPs), which confer defense upon systemic infection. 35 AMPs and lysozymes, a group of digestive enzymes with antimicrobial properties, are 36 expressed in the gut and are good candidates for microbiota regulation. Here, we take advantage 37 of the model organism Drosophila melanogaster to investigate the role of AMPs and lysozymes 38 in regulation of gut microbiota structure and diversity. 39 40 Using flies lacking AMPs and newly generated lysozyme mutants, we colonized gnotobiotic 41 flies with a defined set of commensal bacteria and analyzed changes in microbiota composition 42 and abundance in vertical transmission and aging contexts through 16S rRNA gene amplicon 43 sequencing. Our study shows that AMPs and, to a lesser extent, lysozymes are necessary to 44 regulate the total and relative abundance of bacteria in the gut microbiota. We also decouple 45 the direct function of AMPs from the IMD signaling pathway that regulates AMPs but also 46 many other processes, more narrowly defining the role of these effectors in the microbial 47 dysbiosis observed in IMD-deficient flies upon aging. 48 49 Importance 50 This study advances current knowledge in the field of host-microbe interactions by 51 demonstrating that the two families of immune effectors, antimicrobial peptides and lysozymes, 52 actively regulate the gut microbiota composition and abundance. Consequences of the loss of 53 these antimicrobial peptides and lysozymes are exacerbated during aging, and their loss 54 contributes to increased microbiota abundance and shifted composition in old flies. This work 55 shows that immune effectors, typically associated with resistance to pathogenic infections, also 56 help shape the beneficial gut community, consistent with the idea that host-symbiont 57 interactions use the same ‘language’ typically associated with pathogenesis. 58 bioRxiv preprint doi: https://doi.org/10.1101/2021.03.19.436153; this version posted March 19, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 59 Introduction 60 61 The microbiota is the complex array of microbes commonly associated with the digestive tract 62 of animals. This bacterial consortium greatly affects host physiology, for example by promoting 63 immune function or intestinal homeostasis (1–4). Imbalance of the microbiota, called dysbiosis, 64 has been identified as a cause of gut dysplasia and chronic inflammatory diseases, especially 65 during aging (5). 66 The fruit fly Drosophila melanogaster is a powerful model to decipher host-microbe 67 interactions (6–8). Its genetic tractability, the possibility to generate gnotobiotic animals and 68 the simplicity of its natural microbiota have made Drosophila melanogaster a convenient model 69 to gain insight into host-microbiota relationships (7, 9, 10). Drosophila harbors a simple gut 70 microbiota composed of only a few dominant species, mainly belonging to Acetobacteraceae 71 and Lactobacillaceae, which influence multiple aspects of fly physiology, such as growth (11, 72 12), behavior (13), lifespan (14) and infection resistance (15, 16). In turn, the microbiota can 73 be shaped by various host and environmental factors such as food composition, or age of the 74 flies (17–21). 75 Innate immunity is a key regulator of microbial abundance in Drosophila (22–25). Upon acute 76 bacterial infection, Drosophila immune responsive tissues (the fat body and hemocytes in 77 systemic infection, and epithelium in local infection) sense microbe-associated molecular 78 patterns (MAMPs) to activate signaling pathways. In Drosophila, two immune pathways, the 79 Immune deficiency (IMD) and Toll pathways, regulate the expression of genes encoding 80 immune effectors that fight invading microbes (22, 26, 27). Studies in Drosophila have revealed 81 a key role of the IMD pathway in the gut to fight pathogens and keep symbiotic bacteria in 82 check (28–30). It is however unclear how the IMD pathway can effectively combat pathogens 83 but tolerate symbiotic microbiota members in the digestive tract. In fact, the microbiota induces 84 a low level of activation of the IMD pathway (28). Several reports have demonstrated that 85 immune tolerance towards the indigenous microbiota is sustained by several negative feedback 86 loops that prevent hyperactivation of the IMD pathway by peptidoglycan (the bacterial elicitor 87 recognized by IMD pathway) released from commensal bacteria (31–33). 88 Compartmentalization of the immune response to restricted areas can also favor microbiota 89 growth and control (34, 35). However, IMD pathway activation is necessary to regulate both 90 microbiota composition and proliferation, and dysregulation of this pathway leads to abnormal 91 bacterial growth and premature death of the host (28, 32, 33, 36). Notably, mutations affecting bioRxiv preprint doi: https://doi.org/10.1101/2021.03.19.436153; this version posted March 19, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 92 the IMD transcription factor Relish lead to a higher gut microbiota load and a shifted bacterial 93 composition compared to wild-type flies (28, 37). Moreover, aged Relish mutant flies display 94 dysbiosis associated with a loss of gut epithelium integrity and premature death of the animals 95 (21, 38). Collectively, these studies point to an important role of the IMD pathway in control 96 of the microbiota, notably during aging. However, the IMD pathway regulates hundreds of 97 immune effectors, and affects numerous physiological processes such as enterocyte 98 delamination and digestion (39–43). As previous studies have used mutations that suppress the 99 whole pathway (e.g Relish), the precise role of individual immune effectors downstream of the 100 IMD pathway in shaping the gut microbial community has remained elusive. 101 Antimicrobial peptides (AMPs) are molecules that contribute to innate defenses by targeting 102 the negatively charged membranes of microbes (27). These peptides are produced in large 103 quantities by the fat body during systemic infection, but also in local epithelia such as the gut. 104 Seven classic families of inducible AMPs with several isoforms have been identified in D. 105 melanogaster (27, 44). Use of CRISPR/CAS9 has recently enabled the generation of individual 106 and combined AMP mutants, allowing direct investigation of their role in host defense (45) . 107 Hanson et al. showed that Drosophila AMPs are essential for resisting infection by Gram- 108 negative bacteria that trigger the IMD pathway, but appear to be less involved in defense against 109 Gram-positive bacterial infection (45). 110 Another key group of effector proteins that are potential regulators of Gram-positive bacteria 111 in the gut are the lysozymes (46, 47). Lysozymes specifically cleave peptidoglycan exposed on 112 the cell wall of Gram-positive bacteria (48). The Drosophila genome encodes at least 17 113 putative lysozymes, whose functions have never been formally addressed. Among them, six 114 lysozyme genes (LysB, D, E, P, S, and X) are clustered in the genome at cytogenetic map 115 position 61F. This group of lysozyme genes, notably LysB, LysD, LysE, and LysP, is strongly 116 expressed in the digestive tract (46), and may contribute to digestive activities of the gut by 117 degrading peptidoglycan from dietary bacteria. Furthermore, lysozyme genes are expressed in 118 the gut upon microbiota colonization in Drosophila, and these proteins have been proposed to 119 modulate immune signaling (28, 31, 49). Lysozymes may contribute to gut immunity either as 120 direct antimicrobials, or by cleaving peptidoglycan and modulating activation of the IMD 121 pathway (31).
Recommended publications
  • ERC Advanced Grant 2008 Project Acronym Title Principal Investigator Host Institution Host Country 226037 NSYS Nonlinear System
    ERC Advanced Grant 2008 Project Acronym Title Principal Investigator Host Institution Host Country Nonlinear System Identification and Analysis in the Time, Prof. Stephen Alec 226037 NSYS THE UNIVERSITY OF SHEFFIELD UK Frequency, and Spatio-Temporal Domains Billings HOWTOCONT Search for mechanisms to control massless electrons in 226043 ROLGRAPHE Prof. Carlo Beenakker UNIVERSITEIT LEIDEN. NL graphene NE THE HEBREW UNIVERSITY OF 226135 EXPANDERS Expander Graphs in Pure and Applied Mathematics Prof. Alexander Lubotzky IL JERUSALEM. 226136 VISCHEM Visualizing Molecular Change Prof. Villy Sundström LUNDS UNIVERSITET SE Consistent computation of the chemistry-cloud THE CYPRUS RESEARCH AND 226144 C8 Prof. Johannes Lelieveld CY continuum and climate change in Cyprus EDUCATIONAL FOUNDATION Modern Approaches to Temperature Reconstructions in 226172 MATRICS Dr. Hubertus Fischer UNIVERSITAET BERN CH polar Ice Cores FUndamental studies and innovative appROaches of Prof. Roland Martin 226180 FURORE UNIVERSITAET HAMBURG DE REsearch on magnetism Wiesendanger EBERHARD KARLS 226187 SOCATHES Solid State/Cold Atom Hybrid Quantum Devices Prof. Reinhold Kleiner DE UNIVERSITAET TUEBINGEN KUNGLIGA TEKNISKA 226203 APPROXNP Approximation of NP-hard optimization problems Prof. Johan Håstad SE HOEGSKOLAN Patchy colloidal particles: a powerful arsenal for the PATCHYCOLL fabrication of tomorrow new super-molecules . A UNIVERSITA DEGLI STUDI DI 226207 Prof. Francesco Sciortino IT OIDS theoretical and numerical study of their assembly ROMA LA SAPIENZA processes. ERC Advanced Grant 2008 Analytic Techniques for Geometric and Functional UNIVERSITA DEGLI STUDI DI 226234 ANTEGEFI Prof. Nicola Fusco IT Inequalities NAPOLI FEDERICO II. Multiscale Models for Catalytic-Reaction-Coupled 226238 MMFCS Prof. Bengt Sundén LUNDS UNIVERSITET SE Transport Phenomena in Fuel Cells WEIZMANN INSTITUTE OF 226246 NANOSQUID Scanning Nano-SQUID on a Tip Prof.
    [Show full text]
  • Preparation of Recombinant Rat Eosinophil-Associated Ribonuclease-1 and -2 and Analysis of Their Biological Activities
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Biochimica et Biophysica Acta 1638 (2003) 164–172 www.bba-direct.com Preparation of recombinant rat eosinophil-associated ribonuclease-1 and -2 and analysis of their biological activities Kenji Ishiharaa, Kanako Asaia, Masahiro Nakajimaa, Suetsugu Mueb, Kazuo Ohuchia,* a Laboratory of Pathophysiological Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba Aramaki, Aoba-ku, Sendai, Miyagi 980-8578, Japan b Department of Health and Welfare Science, Faculty of Physical Education, Sendai College, Funaoka, Shibata, Miyagi 989-1693, Japan Received 4 July 2002; received in revised form 22 April 2003; accepted 2 May 2003 Abstract Rat eosinophils contain eosinophil-associated ribonucleases (Ears) in their granules. Ears are thought to be synthesized as pre-forms and stored in the granules as mature forms. However, the N-terminal amino acid of mature Ear-1 and Ear-2 is still controversial. Therefore, we prepared two recombinant mature forms of Ear-1 and Ear-2 in which the N-terminal amino acids are Ser24 (S) [Ear-1 (S) and Ear-2 (S)] and Gln26 (Q) [Ear-1 (Q) and Ear-2 (Q)], and analyzed their biological activities by comparing them with those of pre-form Ear-1 and pre-form Ear-2. The four mature Ears showed RNase A activity as well as bovine pancreatic RNase A activity, but pre-Ear-1 and pre-Ear-2 showed no RNase A activity. Mature Ear-1 (Q) and mature Ear-2 (Q) showed more potent RNase A activity than mature Ear-1 (S) and mature Ear-2 (S), respectively.
    [Show full text]
  • A Bioinformatic Study of Antimicrobial Peptides Identified in The
    www.nature.com/scientificreports OPEN A bioinformatic study of antimicrobial peptides identifed in the Black Soldier Fly (BSF) Hermetia illucens (Diptera: Stratiomyidae) Antonio Moretta1, Rosanna Salvia1, Carmen Scieuzo1, Angela Di Somma2, Heiko Vogel3, Pietro Pucci4, Alessandro Sgambato5,6, Michael Wolf7 & Patrizia Falabella1* Antimicrobial peptides (AMPs) play a key role in the innate immunity, the frst line of defense against bacteria, fungi, and viruses. AMPs are small molecules, ranging from 10 to 100 amino acid residues produced by all living organisms. Because of their wide biodiversity, insects are among the richest and most innovative sources for AMPs. In particular, the insect Hermetia illucens (Diptera: Stratiomyidae) shows an extraordinary ability to live in hostile environments, as it feeds on decaying substrates, which are rich in microbial colonies, and is one of the most promising sources for AMPs. The larvae and the combined adult male and female H. illucens transcriptomes were examined, and all the sequences, putatively encoding AMPs, were analysed with diferent machine learning-algorithms, such as the Support Vector Machine, the Discriminant Analysis, the Artifcial Neural Network, and the Random Forest available on the CAMP database, in order to predict their antimicrobial activity. Moreover, the iACP tool, the AVPpred, and the Antifp servers were used to predict the anticancer, the antiviral, and the antifungal activities, respectively. The related physicochemical properties were evaluated with the Antimicrobial Peptide Database Calculator and Predictor. These analyses allowed to identify 57 putatively active peptides suitable for subsequent experimental validation studies. With over one million described species, insects represent the most diverse as well as the largest class of organ- isms in the world, due to their ability to adapt to recurrent changes and to their resistance against a wide spectrum of pathogens1.
    [Show full text]
  • Redox Active Antimicrobial Peptides in Controlling Growth of Microorganisms at Body Barriers
    antioxidants Review Redox Active Antimicrobial Peptides in Controlling Growth of Microorganisms at Body Barriers Piotr Brzoza 1 , Urszula Godlewska 1,† , Arkadiusz Borek 2, Agnieszka Morytko 1, Aneta Zegar 1 , Patrycja Kwiecinska 1 , Brian A. Zabel 3, Artur Osyczka 2, Mateusz Kwitniewski 1 and Joanna Cichy 1,* 1 Department of Immunology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Kraków, Poland; [email protected] (P.B.); [email protected] (U.G.); [email protected] (A.M.); [email protected] (A.Z.); [email protected] (P.K.); [email protected] (M.K.) 2 Department of Molecular Biophysics, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Kraków, Poland; [email protected] (A.B.); [email protected] (A.O.) 3 Palo Alto Veterans Institute for Research, VA Palo Alto Health Care System, Palo Alto, CA 94304, USA; [email protected] * Correspondence: [email protected] † Present address: Laboratory of Molecular Biology, Faculty of Physiotherapy, The Jerzy Kukuczka Academy of Physical Education, 40-065 Katowice, Poland. Abstract: Epithelia in the skin, gut and other environmentally exposed organs display a variety of mechanisms to control microbial communities and limit potential pathogenic microbial invasion. Naturally occurring antimicrobial proteins/peptides and their synthetic derivatives (here collectively Citation: Brzoza, P.; Godlewska, U.; referred to as AMPs) reinforce the antimicrobial barrier function of epithelial cells. Understanding Borek, A.; Morytko, A.; Zegar, A.; how these AMPs are functionally regulated may be important for new therapeutic approaches to Kwiecinska, P.; Zabel, B.A.; Osyczka, A.; Kwitniewski, M.; Cichy, J.
    [Show full text]
  • Exploring the Mechanism of Action of Human Antimicrobial Ribonucleases
    Doctoral thesis EXPLORING THE MECHANISM OF ACTION OF HUMAN ANTIMICROBIAL RIBONUCLEASES VIVIAN ANGÉLICA SALAZAR MONTOYA Barcelona, 2015 EXPLORING THE MECHANISM OF ACTION OF HUMAN ANTIMICROBIAL RIBONUCLEASES Tesis presentada por Vivian Angélica Salazar Montoya para optar al grado de Doctor en Bioquímica y Biología Molecular. Dirección de Tesis: Dra. Ester Boix y Dr. Mohamed Moussaoui Dra. Ester Boix Borras Dr. Mohamed Moussaoui Vivian A. Salazar M Departamento de Bioquímica y Biología Molecular Facultad de Biociencias Cerdanyola del Vallès Barcelona, España 2015 List of papers included in the thesis Protein post-translational modification in host defence: the antimicrobial mechanism of action of human eosinophil cationic protein native forms. Salazar VA, Rubin J, Moussaoui M, Pulido D, Nogués MV, Venge P and Boix E. (2014). FEBS Journal 281 (24): 5432–46 Human secretory RNases as multifaceted antimicrobial proteins. Exploring RNase 3 and RNase 7 mechanism of action against Candida albicans. Salazar VA, Arranz J, Navarro S, Sánchez D, Nogués MV, Moussaoui M and Boix E. Submitted to Molecular Microbiology List of other papers related to the thesis Structural determinants of the eosinophil cationic protein antimicrobial activity. Boix E, Salazar VA, Torrent M, Pulido D, Nogués MV, Moussaoui M. (2012). Biological Chemistry 393 (8):801-815. “Searching for heparin Binding Partners” in Heparin: Properties, Uses and Side effects. Boix E, Torrent M, Nogués MV, Salazar V. Nova Science Publisher (2012): 133-157. Related structures submitted to the Protein Data Bank 4OXF Structure of ECP in complex with citrate ions at 1.50 Å 4OWZ Structure of ECP/H15A mutant GENERAL INDEX ABBREVIATIONS.......................................................................................................... i RESUMEN .....................................................................................................................
    [Show full text]
  • Lysozyme Enhances the Bactericidal Effect of BP100 Peptide Against Erwinia Amylovora, the Causal Agent of Fire Blight of Rosaceo
    Cabrefiga and Montesinos BMC Microbiology (2017) 17:39 DOI 10.1186/s12866-017-0957-y RESEARCH ARTICLE Open Access Lysozyme enhances the bactericidal effect of BP100 peptide against Erwinia amylovora, the causal agent of fire blight of rosaceous plants Jordi Cabrefiga and Emilio Montesinos* Abstract Background: Fire blight is an important disease affecting rosaceous plants. The causal agent is the bacteria Erwinia amylovora which is poorly controlled with the use of conventional bactericides and biopesticides. Antimicrobial peptides (AMPs) have been proposed as a new compounds suitable for plant disease control. BP100, a synthetic linear undecapeptide (KKLFKKILKYL-NH2), has been reported to be effective against E. amylovora infections. Moreover, BP100 showed bacteriolytic activity, moderate susceptibility to protease degradation and low toxicity. However, the peptide concentration required for an effective control of infections in planta is too high due to some inactivation by tissue components. This is a limitation beause of the high cost of synthesis of this compound. We expected that the combination of BP100 with lysozyme may produce a synergistic effect, enhancing its activity and reducing the effective concentration needed for fire blight control. Results: The combination of a synhetic multifunctional undecapeptide (BP100) with lysozyme produces a synergistic effect. We showed a significant increase of the antimicrobial activity against E. amylovora that was associated to the increase of cell membrane damage and to the reduction of cell metabolism. Combination of BP100 with lysozyme reduced the time required to achieve cell death and the minimal inhibitory concentration (MIC), and increased the activity of BP100 in the presence of leaf extracts even when the peptide was applied at low doses.
    [Show full text]
  • A Comprehensive Database of Antimicrobial Peptides of Dairy Origin Jérémie Théolier, Ismail Fliss, Julie Jean, Riadh Hammami
    MilkAMP: a comprehensive database of antimicrobial peptides of dairy origin Jérémie Théolier, Ismail Fliss, Julie Jean, Riadh Hammami To cite this version: Jérémie Théolier, Ismail Fliss, Julie Jean, Riadh Hammami. MilkAMP: a comprehensive database of antimicrobial peptides of dairy origin. Dairy Science & Technology, EDP sciences/Springer, 2014, 94 (2), pp.181-193. 10.1007/s13594-013-0153-2. hal-01234856 HAL Id: hal-01234856 https://hal.archives-ouvertes.fr/hal-01234856 Submitted on 27 Nov 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Dairy Sci. & Technol. (2014) 94:181–193 DOI 10.1007/s13594-013-0153-2 ORIGINAL PAPER MilkAMP: a comprehensive database of antimicrobial peptides of dairy origin Jérémie Théolier & Ismail Fliss & Julie Jean & Riadh Hammami Received: 16 May 2013 /Revised: 9 October 2013 /Accepted: 11 October 2013 / Published online: 6 November 2013 # INRA and Springer-Verlag France 2013 Abstract The number of identified and characterized bioactive peptides derived from milk proteins is increasing. Although many antimicrobial peptides of dairy origin are now well known, important structural and functional information is still missing or unavailable to potential users. The compilation of such information in one centralized resource such as a database would facilitate the study of the potential of these peptides as natural alternatives for food preservation or to help thwart antibiotic resistance in pathogenic bacteria.
    [Show full text]
  • Activity by Specific Inhibition of Myeloperoxidase Hlf1-11 Exerts Immunomodulatory Effects the Human Lactoferrin-Derived Peptide
    The Human Lactoferrin-Derived Peptide hLF1-11 Exerts Immunomodulatory Effects by Specific Inhibition of Myeloperoxidase Activity This information is current as of September 25, 2021. Anne M. van der Does, Paul J. Hensbergen, Sylvia J. Bogaards, Medine Cansoy, André M. Deelder, Hans C. van Leeuwen, Jan W. Drijfhout, Jaap T. van Dissel and Peter H. Nibbering J Immunol 2012; 188:5012-5019; Prepublished online 20 Downloaded from April 2012; doi: 10.4049/jimmunol.1102777 http://www.jimmunol.org/content/188/10/5012 http://www.jimmunol.org/ References This article cites 39 articles, 13 of which you can access for free at: http://www.jimmunol.org/content/188/10/5012.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 25, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology The Human Lactoferrin-Derived Peptide hLF1-11 Exerts Immunomodulatory Effects by Specific Inhibition of Myeloperoxidase Activity Anne M.
    [Show full text]
  • Vitamin D-Cathelicidin Axis: at the Crossroads Between Protective Immunity and Pathological Inflammation During Infection
    Immune Netw. 2020 Apr;20(2):e12 https://doi.org/10.4110/in.2020.20.e12 pISSN 1598-2629·eISSN 2092-6685 Review Article Vitamin D-Cathelicidin Axis: at the Crossroads between Protective Immunity and Pathological Inflammation during Infection Chaeuk Chung 1, Prashanta Silwal 2,3, Insoo Kim2,3, Robert L. Modlin 4,5, Eun-Kyeong Jo 2,3,6,* 1Division of Pulmonary and Critical Care, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon 35015, Korea Received: Oct 27, 2019 2Infection Control Convergence Research Center, Chungnam National University School of Medicine, Revised: Jan 28, 2020 Daejeon 35015, Korea Accepted: Jan 30, 2020 3Department of Microbiology, Chungnam National University School of Medicine, Daejeon 35015, Korea 4Division of Dermatology, Department of Medicine, David Geffen School of Medicine at the University of *Correspondence to California, Los Angeles, Los Angeles, CA 90095, USA Eun-Kyeong Jo 5Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Department of Microbiology, Chungnam Los Angeles, CA 90095, USA National University School of Medicine, 282 6Department of Medical Science, Chungnam National University School of Medicine, Daejeon 35015, Korea Munhwa-ro, Jung-gu, Daejeon 35015, Korea. E-mail: [email protected] Copyright © 2020. The Korean Association of ABSTRACT Immunologists This is an Open Access article distributed Vitamin D signaling plays an essential role in innate defense against intracellular under the terms of the Creative Commons microorganisms via the generation of the antimicrobial protein cathelicidin. In addition Attribution Non-Commercial License (https:// to directly binding to and killing a range of pathogens, cathelicidin acts as a secondary creativecommons.org/licenses/by-nc/4.0/) messenger driving vitamin D-mediated inflammation during infection.
    [Show full text]
  • The Human Cathelicidin LL-37 — a Pore-Forming Antibacterial Peptide and Host-Cell Modulator☆
    Biochimica et Biophysica Acta 1858 (2016) 546–566 Contents lists available at ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbamem The human cathelicidin LL-37 — A pore-forming antibacterial peptide and host-cell modulator☆ Daniela Xhindoli, Sabrina Pacor, Monica Benincasa, Marco Scocchi, Renato Gennaro, Alessandro Tossi ⁎ Department of Life Sciences, University of Trieste, via Giorgeri 5, 34127 Trieste, Italy article info abstract Article history: The human cathelicidin hCAP18/LL-37 has become a paradigm for the pleiotropic roles of peptides in host de- Received 7 August 2015 fence. It has a remarkably wide functional repertoire that includes direct antimicrobial activities against various Received in revised form 30 October 2015 types of microorganisms, the role of ‘alarmin’ that helps to orchestrate the immune response to infection, the Accepted 5 November 2015 capacity to locally modulate inflammation both enhancing it to aid in combating infection and limiting it to pre- Available online 10 November 2015 vent damage to infected tissues, the promotion of angiogenesis and wound healing, and possibly also the elimi- Keywords: nation of abnormal cells. LL-37 manages to carry out all its reported activities with a small and simple, Cathelicidin amphipathic, helical structure. In this review we consider how different aspects of its primary and secondary LL-37 structures, as well as its marked tendency to form oligomers under physiological solution conditions and then hCAP-18 bind to molecular surfaces as such, explain some of its cytotoxic and immunomodulatory effects. We consider CRAMP its modes of interaction with bacterial membranes and capacity to act as a pore-forming toxin directed by our Host defence peptide organism against bacterial cells, contrasting this with the mode of action of related peptides from other species.
    [Show full text]
  • Imaging the Action of Antimicrobial Peptides on Living Bacterial Cells SUBJECT AREAS: Michelle L
    Imaging the action of antimicrobial peptides on living bacterial cells SUBJECT AREAS: Michelle L. Gee1, Matthew Burton1, Alistair Grevis-James1, Mohammed Akhter Hossain2, Sally McArthur3, SURFACES, INTERFACES 4 2 5 AND THIN FILMS Enzo A. Palombo , John D. Wade & Andrew H. A. Clayton BIOPHYSICAL METHODS 1 2 SUPRAMOLECULAR ASSEMBLY School of Chemistry, University of Melbourne, Parkville, Victoria 3010, Australia, Howard Florey Institute, University of Melbourne, Parkville, Victoria 3010, Australia, 3Industrial Research Institute Swinburne, Faculty of Engineering and Industrial MEMBRANE STRUCTURE AND Sciences, Swinburne University of Technology, Hawthorn, Victoria 3122, Australia, 4Faculty of Life and Social Sciences, Swinburne ASSEMBLY University of Technology, Hawthorn, Victoria 3122, Australia, 5Centre for Micro-Photonics, Faculty of Engineering and Industrial Sciences, Swinburne University of Technology, Hawthorn, Victoria 3122, Australia. Received 3 September 2012 Antimicrobial peptides hold promise as broad-spectrum alternatives to conventional antibiotics. The Accepted mechanism of action of this class of peptide is a topical area of research focused predominantly on their interaction with artificial membranes. Here we compare the interaction mechanism of a model 6 March 2013 antimicrobial peptide with single artificial membranes and live bacterial cells. The interaction kinetics was Published imaged using time-lapse fluorescence lifetime imaging of a fluorescently-tagged melittin derivative. 27 March 2013 Interaction with the synthetic membranes resulted in membrane pore formation. In contrast, the interaction with bacteria led to transient membrane disruption and corresponding leakage of the cytoplasm, but surprisingly with a much reduced level of pore formation. The discovery that pore formation is a less significant part of lipid-peptide interaction in live bacteria highlights the mechanistic complexity of these Correspondence and interactions in living cells compared to simple artificial systems.
    [Show full text]
  • A Single Modular Serine Protease Integrates Signals from Pattern-Recognition Receptors Upstream of the Drosophila Toll Pathway
    A single modular serine protease integrates signals from pattern-recognition receptors upstream of the Drosophila Toll pathway Nicolas Buchona,1, Mickael Poidevinb,1, Hyun-Mi Kwonc, Aure´ lien Guilloua, Valentin Sottasa, Bok-Luel Leec, and Bruno Lemaitrea,b,2 aGlobal Health Institute, Ecole Polytechnique Fe´de´ rale de Lausanne, 1015 Lausanne, Switzerland; bCentre de Ge´ne´ tique Mole´culaire (CGM), Centre National de la Recherche Scientifique, 91198 Gif-sur-Yvette, France; and cNational Research Laboratory of Defense Proteins, College of Pharmacy, Pusan National University, Kumjeong Ku, Busan 609-735, Korea Edited by Frederick M. Ausubel, Harvard Medical School, Boston, MA, and approved June 1, 2009 (received for review February 23, 2009) The Drosophila Toll receptor does not interact directly with microbial extended to the sensing of proteases produced by various bacteria determinants, but is instead activated by a cleaved form of the (11). Surprisingly, tracheal melanization in mutant larvae lacking cytokine-like molecule Spa¨tzle. During the immune response, Spa¨tzle the serpin Spn77Ba also activates the Toll pathway in a Psh- is processed by complex cascades of serine proteases, which are dependent manner (12). This suggests that Psh-dependent Toll activated by secreted pattern-recognition receptors. Here, we dem- pathway activation is induced by a host factor derived from mela- onstrate the essential role of ModSP, a modular serine protease, in the nization. This also points to a possible cross-talk between the activation of the Toll pathway by Gram-positive bacteria and fungi. proteolytic cascades that regulate the Toll pathway and those Our analysis shows that ModSP integrates signals originating from regulating the melanization reaction.
    [Show full text]